TABLE OF CONTENTS
EXECUTIVE SUMMARY 2
MARKET OVERVIEW 7
Market definition 7
Research highlights 8
Market analysis 9
MARKET VALUE 10
MARKET SEGMENTATION I 11
MARKET SEGMENTATION II 12
MARKET SHARE 13
FIVE FORCES ANALYSIS 14
Summary 14
Buyer power 16
Supplier power 17
New entrants 18
Substitutes 20
Rivalry 21
LEADING COMPANIES 22
Johnson & Johnson 22
Béres Pharmaceuticals Co. Ltd 27
EGIS Pharmaceuticals Ltd. 28
MARKET DISTRIBUTION 32
MARKET FORECASTS 33
Market value forecast 33
MACROECONOMIC INDICATORS 34
APPENDIX 36
Methodology 36
Industry associations 37
Related Datamonitor research 37
Disclaimer 39
ABOUT DATAMONITOR 40
Premium Reports 40
Summary Reports 40
Datamonitor consulting 40
LIST OF TABLES
Table 1: Hungary OTC pharmaceuticals market value: $ million, 2005–09 10
Table 2: Hungary OTC pharmaceuticals market segmentation I:% share, by value, 2009 11
Table 3: Hungary OTC pharmaceuticals market segmentation II: % share, by value, 2009 12
Table 4: Hungary OTC pharmaceuticals market share: % share, by value, 2009 13
Table 5: Johnson & Johnson: key facts 22
Table 6: Johnson & Johnson: key financials ($) 24
Table 7: Johnson & Johnson: key financial ratios 25
Table 8: Béres Pharmaceuticals Co. Ltd: key facts 27
Table 9: EGIS Pharmaceuticals Ltd.: key facts 28
Table 10: EGIS Pharmaceuticals Ltd.: key financials ($) 29
Table 11: EGIS Pharmaceuticals Ltd.: key financials (HUF) 29
Table 12: EGIS Pharmaceuticals Ltd.: key financial ratios 30
Table 13: Hungary OTC pharmaceuticals market distribution: % share, by value, 2009 32
Table 14: Hungary OTC pharmaceuticals market value forecast: $ million, 2009–14 33
Table 15: Hungary size of population (million), 2005–09 34
Table 16: Hungary gdp (constant 2000 prices, $ billion), 2005–09 34
Table 17: Hungary gdp (current prices, $ billion), 2005–09 34
Table 18: Hungary inflation, 2005–09 35
Table 19: Hungary consumer price index (absolute), 2005–09 35
Table 20: Hungary exchange rate, 2005–09 35
LIST OF FIGURES
Figure 1: Hungary OTC pharmaceuticals market value: $ million, 2005–09 10
Figure 2: Hungary OTC pharmaceuticals market segmentation I:% share, by value, 2009 11
Figure 3: Hungary OTC pharmaceuticals market segmentation II: % share, by value, 2009 12
Figure 4: Hungary OTC pharmaceuticals market share: % share, by value, 2009 13
Figure 5: Forces driving competition in the OTC pharmaceuticals market in Hungary, 2009 14
Figure 6: Drivers of buyer power in the OTC pharmaceuticals market in Hungary, 2009 16
Figure 7: Drivers of supplier power in the OTC pharmaceuticals market in Hungary, 2009 17
Figure 8: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Hungary, 2009 18
Figure 9: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Hungary, 2009 20
Figure 10: Drivers of degree of rivalry in the OTC pharmaceuticals market in Hungary, 2009 21
Figure 11: Johnson & Johnson: revenues & profitability 25
Figure 12: Johnson & Johnson: assets & liabilities 26
Figure 13: EGIS Pharmaceuticals Ltd.: revenues & profitability 30
Figure 14: EGIS Pharmaceuticals Ltd.: assets & liabilities 31
Figure 15: Hungary OTC pharmaceuticals market distribution: % share, by value, 2009 32
Figure 16: Hungary OTC pharmaceuticals market value forecast: $ million, 2009–14 33
[Fade out table of contents]
